Legal Information Sold for research purposes under agreement from Pfizer Inc. Biochem/physiol Actions Maraviroc is a CCR5 chemokine receptor antagonist, and antiretroviral entry inhibitor. Maraviroc inhibits HIV entry by blocking interaction of viral coat protein gp120 with the receptor.